Updates on OXiGENE, Inc.

0 Comments | M2 Presswire, June, 2006

M2 PRESSWIRE-19 June 2006-marketgainer.com: Updates on OXiGENE, Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:19062006 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Today's activity on the Nasdaq exchange has brought OXiGENE, Inc (NASDAQ:OXGN) to the attention of our research team.

Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Shares up $.23 to a high of $3.67 on the Nasdaq Monday. Momentum comes as OXiGENE, Inc., a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)